Browse
Search
2017-388 Health - UNC Health Care System for BCCCP mammogram screenings
OrangeCountyNC
>
Board of County Commissioners
>
Contracts and Agreements
>
General Contracts and Agreements
>
2010's
>
2017
>
2017-388 Health - UNC Health Care System for BCCCP mammogram screenings
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/3/2018 2:11:22 PM
Creation date
9/6/2017 9:22:39 AM
Metadata
Fields
Template:
Contract
Date
7/1/2017
Contract Starting Date
7/1/2017
Contract Ending Date
6/30/2018
Contract Document Type
Contract
Amount
$4,000.00
Document Relationships
R 2017-388 Health - UNC Health Care System for BCCCP mammogram screenings
(Linked To)
Path:
\Board of County Commissioners\Contracts and Agreements\Contract Routing Sheets\Routing Sheets\2017
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
10
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
North Carolina Breast and Cervical Cancer Control Program <br /> 2017 Services Fee Schedule(1) <br /> NOTES: <br /> (1) NC BCCCP covers only the physician's fee. Any facility charges associated with these CPT codes are not covered <br /> (2) Code 77063 should be listed as a separate code in addition to the code for the screening mammogram code,77057 or <br /> (3) Code G0279 should be listed as a separate code in addition to G0204 or G0206 for the primary mammogram. <br /> (4) Codes 19081-19084 are to be used for breast biopsies that include image guidance,placement of localization device,and <br /> imaging of specimen.These codes should not be used in conjunction with 19281-19286. <br /> (5) Codes 19281-19286 are for image guidance placement of localization device without image-guided biopsy.These codes <br /> should not be used in conjunction with 19081-19084. <br /> (6) HPV DNA testing is a reimbursable procedure if used for screening in conjunction with Pap testing or for follow-up of an <br /> abnormal Pap or surveillance per ASCCP guidelines. It is not reimbursable as a primary screening test for women of all <br /> ages or as an adjunctive screening test to the Pap for women under 30 years of age. Providers should specify the high-risk <br /> HPV DNA panel only.Reimbursement of screening for low-risk HPV types is not permitted. <br /> The CDC will allow for reimbursement of Cervista HPV HR at the same rate as the Digene Hybrid Capture 2 HPV DNA <br /> CDC funds may be used for reimbursement of HPV genotyping. <br /> (7) All consultations should be billed through the standard"new patient"office visit CPT codes:99201-99205. Consultations <br /> billed as 99204 or 99205 must meet the criteria for these codes,and must be pre-authorized. Codes 99204 and 99205 are <br /> not appropriate for NC BCCCP screening visits. <br /> N.C.Department of Health and Human Services,Division of Public Health, Page 5 <br /> Chronic Disease and Injury Section,Cancer Prevention and Control Branch 2/2017 <br />
The URL can be used to link to this page
Your browser does not support the video tag.